INV-043

N/A

Report date: 2025/01/26 19:21:44
NME

Base Information

Drug NameINV-043
Drug Alias Namephotodynamic immunotherapy (Invion/Hudson Institute of Medical Research)INV-043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsBreast NeoplasmsLymphoma, T-Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInvion Inc
China Registration ClassN/A

Develop Information

Active CompaniesInvion Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsBreast NeoplasmsLymphoma, T-Cell
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A